Articles

In a marketplace as diverse as biotech, picking the best and brightest can stymie even the savviest investor. VIEW MORE[+]

As it advances its pipeline of drugs further, NanoViricides says it has filed an orphan drug application with U.S. regulatory authorities for DengueCide VIEW MORE[+]

Pressure BioSciences says it has a new high throughput (HT) design for its patented pressure cycling technology (PCT) that will integrate its platform with the automated HT sample preparation and anal... VIEW MORE[+]

Sometimes speaking with investors who work half a world away is just what's needed to get a new angle and hear new names. VIEW MORE[+]

Pivotal Therapeutics, a specialty pharmaceutical company focused on Omega-3 therapies for cardiovascular disease (CVD), has narrowed its first quarter losses as the company's marketing program for its... VIEW MORE[+]

If investigators could find a way to make breast cancer survivors truly cancer free, and if a diagnosis of pancreatic cancer were less dire, investors could reap windfalls VIEW MORE[+]

Earlier this week a breakthrough in this field was announced. A group of researchers published in the journal Cell proof that they had created embryonic stem cells through cloning. VIEW MORE[+]

If there’s one profession for which you don’t want students to have learning gaps, it’s medicine. VIEW MORE[+]

Researchers in London have identified a mechanism through which vitamin D can significantly reduce the symptoms of asthma and suggest it may offer a new way to treat the debilitating condition, which ... VIEW MORE[+]

Soligenix, a biopharmaceutical company focused on products for inflammatory diseases and biodefense countermeasures, has taken yet another step toward advancing one of its drugs, saying it has started... VIEW MORE[+]

Stem cell companies have languished long enough in micro-cap territory. VIEW MORE[+]

The Wall Street Analyst conducted a podcast interview with the Company's CEO, Neil Belenkie. VIEW MORE[+]

Pivotal Therapeutics, a specialty pharmaceutical company focused on Omega-3 therapies for cardiovascular disease (CVD), revealed today results from its Vascazen "Reveal" clinical trial, saying the pro... VIEW MORE[+]

Pivotal Therapeutics has said that its founder, chairman and chief scientific officer, Dr. George Jackowski, was awarded the Queen Elizabeth II Diamond Jubilee Medal earlier this week for his contribu... VIEW MORE[+]

Pfizer Inc., the world’s largest drug-maker, trimmed its full-year profit outlook after first-quarter sales and earnings fell short of expectations. VIEW MORE[+]

Advanced Proteome Therapeutics says it has received a notice of issuance for a new U.S. patent with regards to its Foundation Trinity cancer treatment, and has also appointed biotech veteran Edward K.... VIEW MORE[+]

Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective. VIEW MORE[+]

Outsourcing and innovation are among the key elements likely to be key drivers of share price performance of healthcare & life sciences stocks, N+1 Singer reckons. VIEW MORE[+]

Reviewers said on Monday that efficacy data for an experimental drug made by GlaxoSmithKline Plc and Theravance Inc was somewhat inconsistent VIEW MORE[+]

Governments on both sides of the Atlantic are placing big new bets on the future of brain science, just as much of the pharmaceutical industry retreats from the field. VIEW MORE[+]

Shares of BioCryst Pharmaceuticals rose over 20 per cent Monday, after reports on Saturday stated that the China Food and Drug Administration had approved production of the company’s drug Peramivir ... VIEW MORE[+]

Valeant Pharmaceuticals Thursday said its 2013 earnings per share could take a hit of 30 to 40 cents on the launch of a generic version of its Zovirax ointment – used to treat certain types of herpe... VIEW MORE[+]

The White House unveiled details on Tuesday on a new initiative to study the human brain with the goal of treating or curing Alzheimer's disease and other disorders. VIEW MORE[+]

Digital doctors are changing the face of medicine VIEW MORE[+]

Shares of United Therapeutics Corp fell Monday after the company said that U.S. regulatory authorities rejected the approval of its new drug application for oral treprostinil diolamine, for the treatm... VIEW MORE[+]

Pressure BioSciences, a life science company developing pressure cycling technology, or PCT, said that recent research has shown that PCT-based sample preparation methods have yielded improved quality... VIEW MORE[+]

Soligenix says that several preclinical studies have shown that vaccines formulated with its ThermoVax technology have the potential for high temperature stability seen for a minimum of six months and... VIEW MORE[+]

No single solution will emerge from the growing realm of stem cell technology and regenerative medicine. VIEW MORE[+]

Aeterna Zentaris shares plunged over 23 percent in Toronto on Monday after saying that an independent data safety monitoring board has recommended it discontinue the phase 3 study of perifosine in pat... VIEW MORE[+]

NanoViricides saw its shares surge over seven per cent Wednesday, after announcing that president Anil Diwan will lead section 1 of the Symposium on Nanomedicines: Charting a Roadmap to Commercializat... VIEW MORE[+]